Edwards Lifesciences (EW) Work In Process (2010 - 2026)

Edwards Lifesciences has reported Work In Process for 13 years, with the latest figure at $242.2 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process fell 6.92% year-over-year to $242.2 million; the trailing twelve-month figure through Mar 2026 stood at $242.2 million (down 6.92% YoY), and the FY2025 full-year result was $252.9 million, up 7.07% from the prior year.
• Work In Process for Q1 2026 stood at $242.2 million, down from $252.9 million in the prior quarter.
• The five-year high for Work In Process was $275.9 million in Q3 2025, with the low at $195.8 million in Q4 2023.
• Average Work In Process over 4 years is $246.5 million, with a median of $248.6 million recorded in 2024.
• Year-over-year, Work In Process climbed 20.63% in 2024 and declined 6.92% in 2026.
• Tracing EW's Work In Process over 4 years: stood at $195.8 million in 2023, then climbed by 20.63% to $236.2 million in 2024, then rose by 7.07% to $252.9 million in 2025, then decreased by 4.23% to $242.2 million in 2026.
• The last three Work In Process figures came in at $242.2 million (Q1 2026), $252.9 million (Q4 2025), and $275.9 million (Q3 2025), per Business Quant data.

Peer Comparison